1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,133 | 0,156 | 25.04. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.04. | Ventripoint Diagnostics Ltd (2): Ventripoint arranges $3-million debenture financing | 1 | Stockwatch | ||
| 11.04. | Ventripoint Diagnostics Ltd.: Ventripoint Announces Non-Brokered Convertible Debenture Private Placement | - | TheNewswire | ||
| 28.03. | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics outlines quarterly activities | 1 | Stockwatch | ||
| 04.03. | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics releases VMS+3.2 | 1 | Stockwatch | ||
| 13.02. | Ventripoint Diagnostics Ltd (2): Ventripoint appoints Hendriks as partnership executive | 1 | Stockwatch | ||
| 05.02. | Ventripoint Diagnostics Ltd (2): Ventripoint names MacNaught as interim CEO, president | 1 | Stockwatch | ||
| 05.02. | Ventripoint Diagnostics names Hugh MacNaught as its interim CEO | 1 | Seeking Alpha | ||
| 01.02. | Ventripoint Diagnostics Ltd (2): Ventripoint provides VMS+ to Medical University Vienna | 1 | Stockwatch | ||
| 29.01. | Ventripoint Diagnostics Ltd (2): Ventripoint CEO Macanovic reviews 2023 operations | 1 | Stockwatch | ||
| 22.01. | Ventripoint Diagnostics Ltd (2): Ventripoint appoints Mertens to clinical advisory board | 1 | Stockwatch | ||
| 03.01. | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics releases white paper on AI tech | 1 | Stockwatch | ||
| 12.12.23 | Ventripoint Diagnostics Ltd (2): Ventripoint to distribute in NA hospitals via A SCEND | 1 | Stockwatch | ||
| 05.12.23 | Ventripoint Diagnostics Ltd (2): Ventripoint heart-imaging tech to be presented by Ollie | 2 | Stockwatch | ||
| 30.11.23 | VentriPoint Diagnostics reports Q3 results | 1 | Seeking Alpha | ||
| 30.11.23 | Ventripoint Diagnostics Ltd (2): Ventripoint loses $1.17-million in Q3 2023 | 1 | Stockwatch | ||
| 24.11.23 | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics to release Q3 results Nov. 29 | 2 | Stockwatch |
16 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 1,474 | 0,00 % | Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense | ||
| ATOSSA THERAPEUTICS | 1,446 | +1,69 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-Endoxifen | SEATTLE, April 09, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company") today announced promising safety and efficacy data from the Company's Phase 2 EVANGELINE... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023 | -- Third Consecutive Year of Phexxi Net Sales Growth --
-- Total Operating Expense Reduced 64% from 2022 Levels --
-- Sales and marketing expense as a percentage of net sales was 54% for the fourth... ► Artikel lesen | |
| TANDEM DIABETES | 33,700 | +1,63 % | Cracking The Code: Understanding Analyst Reviews For Tandem Diabetes Care | ||
| INVIVO THERAPEUTICS HOLDINGS | 0,318 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.02.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 23.02.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.02.2024.ISIN NameCA58503M4083 MEDIVOLVE... ► Artikel lesen | |
| VOLITIONRX | 0,890 | +10,45 % | VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for Tuesday, March 26 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev., March 25, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE... ► Artikel lesen | |
| VERU | 1,206 | +5,98 % | Veru Inc.: Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11 | ||
| MOLINA HEALTHCARE | 336,10 | +2,41 % | Molina Healthcare Reports First Quarter 2024 Financial Results | LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) (the "Company") today reported first quarter 2024 GAAP earnings per diluted share of $5.17 and adjusted earnings per diluted... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 0,622 | -1,24 % | Clover Health Investments, Corp.: Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer | FRANKLIN, Tenn., April 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement technology company, today announced... ► Artikel lesen | |
| COGNETIVITY NEUROSCIENCES | 0,006 | 0,00 % | Cognetivity Neurosciences Ltd: Cognetivity registers CognICA with TGA in Australia | ||
| TEMPUR SEALY | 45,800 | -1,72 % | Tempur Sealy International, Inc.: Tempur Sealy Provides Update on Mattress Firm Acquisition | - Expects FTC to complete its review by the end of the second quarter
- Continues to expect the transaction to close in mid to late 2024
- Further solidifies key supplier relationships to maintain... ► Artikel lesen | |
| SHL TELEMEDICINE | 5,250 | +2,54 % | SHL Telemedicine Ltd.: SHL Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical Milestones | SHL Telemedicine Ltd. (NASDAQ: SHLT; SIX Swiss Exchange: SHLTN) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, announced today its results... ► Artikel lesen | |
| SINTX TECHNOLOGIES | 0,038 | +11,95 % | SINTX Technologies, Inc.: SINTX Technologies Announces Proposed Public Offering of Common Stock | SALT LAKE CITY, UT, March 29, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), an original equipment manufacturer of advanced ceramics, today announced... ► Artikel lesen | |
| SMILEDIRECTCLUB | 0,004 | 0,00 % | Delisting of Securities of SmileDirectClub, Inc.; Bellerophon Therapeutics, Inc.; Elys Game Technology; Athersys, Inc.; Borqs Technologies; ContraFect Corporation; CohBar, Inc.; AgileThought, Inc.; Fat Projects Acquisition; Evelo Biosciences ... | NEW YORK, Dec. 26, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of SmileDirectClub, Inc. SmileDirectClub, Inc.'s securities were suspended on... ► Artikel lesen | |
| VYANT BIO | 0,232 | 0,00 % | Vyant Bio, Inc.: Vyant Bio Provides Update on Winddown Activities | CHERRY HILL, N.J., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. ("Vyant Bio" or "Company") (OTC: VYNT) is providing an update to shareholders regarding its winddown activities pursuant to its... ► Artikel lesen |
VENTRIPOINT DIAGNOSTICS LTD gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,134 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
